1 Research Way
Princeton, NJ 08540
United States
609 642 6670
https://www.pmvpharma.com
Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 63
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Dr. David H. Mack Ph.D. | Co-Founder, CEO, President & Director | 881,08k | N/A | 1962 |
Dr. Arnold J. Levine Ph.D. | Co-Founder, Director & Member of Scientific Advisory Board | 140k | N/A | 1940 |
Dr. Deepika Jalota Pharm.D. | Chief Development Officer | 593,9k | N/A | 1977 |
Dr. Thomas E. Shenk Ph.D. | Co-Founder & Member of Scientific Advisory Board | N/A | N/A | 1947 |
Mr. Michael Carulli | Chief Financial Officer | N/A | N/A | 1974 |
Mr. Robert Ticktin | General Counsel, Head of Operations & Company Secretary | N/A | N/A | 1962 |
Mr. Tim Smith | Senior VP & Head of Corporate Development and Investor Relations | N/A | N/A | N/A |
Ms. Crystal Zuckerman | Vice President of Human Resources | N/A | N/A | N/A |
Dr. Binh Vu Ph.D. | Senior VP of Drug Discovery & CMC | N/A | N/A | N/A |
Dr. Marc Fellous M.D. | Senior VP and Head of Clinical Development & Medical Affairs | N/A | N/A | N/A |
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
El ISS Governance QualityScore de PMV Pharmaceuticals, Inc., a día 1 de mayo de 2024, es 7. Las puntuaciones base son Auditoría: 6; Tablero: 6; Derechos de los accionistas: 7; Compensación: 8.